Company / Current Assets
ORAMED PHARMACEUTICALS INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$133.3M
FY2025
5-year range
$95.3M / $162.6M
FY2021-FY2025
Trend
-6.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $163M to $133M over the past 2 years.
Based on SEC 10-K filings.
$133M in FY2025 with a 5-year CAGR of +26.9%.
Declined from $163M to $133M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -5.3%
- 5-Year CAGR
- +26.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +26.9%, indicating consistent growth.
- In FY2025, current assets decreased 6.9% year-over-year.
- Peak current assets was recorded in FY2023.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $133.3M | -6.9% |
| FY2024 | $143.2M | -11.9% |
| FY2023 | $162.6M | +3.5% |
| FY2022 | $157.1M | +64.8% |
| FY2021 | $95.3M | +135.3% |
| FY2020 | $40.5M | +21.6% |
| FY2019 | $33.3M | +7.4% |
| FY2018 | $31.0M | +52.9% |
| FY2017 | $20.3M | -35.0% |
| FY2016 | $31.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026